High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.

about

High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.

Item

http://www.wikidata.org/entity/Q48164811

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

High probability and frequency ...... cancer with brain metastases.

@en

High probability and frequency ...... cancer with brain metastases.

@nl

type

Item

label

High probability and frequency ...... cancer with brain metastases.

@en

High probability and frequency ...... cancer with brain metastases.

@nl

prefLabel

High probability and frequency ...... cancer with brain metastases.

@en

High probability and frequency ...... cancer with brain metastases.

@nl

P1476

High probability and frequency ...... cancer with brain metastases.

@en

P2093

Mengxi Ge

http://www.w3.org/2001/XMLSchema#string

Qiong Zhan

http://www.w3.org/2001/XMLSchema#string

Ruofan Huang

http://www.w3.org/2001/XMLSchema#string

Xiaohua Liang

http://www.w3.org/2001/XMLSchema#string

Xinli Zhou

http://www.w3.org/2001/XMLSchema#string

Yingjie Zhuang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Screening for epidermal growth factor receptor mutations in lung cancer

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.

Epidermal growth factor receptor: mechanisms of activation and signalling.

Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer.

Current therapeutic approaches in patients with brain metastases.

Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.

P2888

s11060-017-2590-x

P304

413-418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2590-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28780743

http://www.w3.org/2001/XMLSchema#string